Rapid Therapeutic Science Laboratories, Inc. (RTSL)
USD 0.0
(2.56%)
USD 0.0
(2.56%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | 4.2 Million USD | 134.77% |
| 2021 | 1.79 Million USD | 0.0% |
| 2019 | 2.93 Million USD | 0.0% |
| 2017 | 2.83 Million USD | 12432.79% |
| 2016 | 22.6 Thousand USD | 2866.54% |
| 2015 | 762.00 USD | 107.63% |
| 2014 | -9981.00 USD | 46.21% |
| 2013 | -18.55 Thousand USD | 41.99% |
| 2012 | -31.99 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q1 | 3.75 Million USD | -10.71% |
| 2023 Q2 | 3.78 Million USD | 0.67% |
| 2022 Q4 | 4.2 Million USD | 0.68% |
| 2022 FY | 4.2 Million USD | 134.77% |
| 2022 Q2 | 3.38 Million USD | 6.71% |
| 2022 Q1 | 3.17 Million USD | 77.16% |
| 2022 Q3 | 4.18 Million USD | 23.35% |
| 2021 Q4 | 1.79 Million USD | 5837.55% |
| 2021 Q3 | -31.25 Thousand USD | -107.8% |
| 2021 Q2 | 400.46 Thousand USD | 2891.02% |
| 2021 Q1 | 13.38 Thousand USD | 0.0% |
| 2021 FY | 1.79 Million USD | 0.0% |
| 2020 Q1 | 1.08 Million USD | -1.01% |
| 2020 Q3 | 439.51 Thousand USD | -56.73% |
| 2020 Q2 | 1.01 Million USD | -6.44% |
| 2019 FY | 2.93 Million USD | 0.0% |
| 2019 Q2 | 2.94 Million USD | 0.23% |
| 2019 Q1 | 2.93 Million USD | 0.37% |
| 2019 Q4 | 1.09 Million USD | -62.87% |
| 2019 Q3 | 2.95 Million USD | 0.23% |
| 2018 Q3 | 2.91 Million USD | 0.02% |
| 2018 Q1 | 2.83 Million USD | 52739.13% |
| 2018 Q2 | 2.91 Million USD | 2.94% |
| 2018 Q4 | 2.92 Million USD | 0.4% |
| 2017 FY | 2.83 Million USD | 12432.79% |
| 2017 Q3 | 38.91 Thousand USD | 34.2% |
| 2017 Q4 | -5382.00 USD | -113.83% |
| 2017 Q2 | 29 Thousand USD | 28.29% |
| 2017 Q1 | 22.6 Thousand USD | 59.92% |
| 2016 Q2 | 7970.00 USD | 945.93% |
| 2016 FY | 22.6 Thousand USD | 2866.54% |
| 2016 Q1 | 762.00 USD | 150.36% |
| 2016 Q4 | 14.13 Thousand USD | 47.47% |
| 2016 Q3 | 9585.00 USD | 20.26% |
| 2015 Q2 | -7831.00 USD | 21.54% |
| 2015 Q4 | -1513.00 USD | 68.56% |
| 2015 Q1 | -9981.00 USD | 13.07% |
| 2015 FY | 762.00 USD | 107.63% |
| 2015 Q3 | -4813.00 USD | 38.54% |
| 2014 Q4 | -11.48 Thousand USD | 38.03% |
| 2014 Q2 | -18.55 Thousand USD | 0.0% |
| 2014 Q3 | -18.52 Thousand USD | 0.16% |
| 2014 FY | -9981.00 USD | 46.21% |
| 2014 Q1 | -18.55 Thousand USD | 8.68% |
| 2013 Q4 | -20.32 Thousand USD | 4.47% |
| 2013 FY | -18.55 Thousand USD | 41.99% |
| 2013 Q2 | -21.74 Thousand USD | 0.0% |
| 2013 Q3 | -21.27 Thousand USD | 2.16% |
| 2012 FY | -31.99 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 71.609% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | -1843.337% |
| Polarean Imaging plc | -5.94 Million USD | 170.788% |
| Avitar, Inc. | 5.17 Million USD | 18.598% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | -606 Thousand USD | 794.624% |
| AVITA Medical, Inc. | -26.23 Million USD | 116.047% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 60234.614% |
| Össur hf. | 395.08 Million USD | 98.935% |
| Zecotek Photonics Inc. | 2.76 Million USD | -52.38% |
| QHSLab, Inc. | 1.72 Million USD | -143.323% |
| Wellstar International, Inc. | 51.36 Million USD | 91.805% |
| Össur hf. | 395.08 Million USD | 98.935% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 191.169% |
| Escalon Medical Corp. | 315.68 Thousand USD | -1233.421% |
| Aurora Spine Corporation | 1.9 Million USD | -120.66% |
| BrainsWay Ltd. | -10.32 Million USD | 140.789% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 2.41 Million USD | -74.301% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 76.777% |
| Vivos Inc. | -1.59 Million USD | 364.363% |
| MicroPort Scientific Corporation | 673.58 Million USD | 99.375% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | -763.767% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 878.102% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | -557.52% |
| Nanomix Corporation | 11.38 Million USD | 63.04% |
| Theraclion SA | -5.86 Million EUR | 171.778% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | -5.619% |
| Positron Corporation | 1.68 Million USD | -149.539% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | -161.318% |
| Lombard Medical, Inc. | 11.49 Million USD | 63.38% |
| ALR Technologies Inc. | 19.14 Million USD | 78.017% |
| Stratec SE | 119.12 Million USD | 96.466% |
| Vycor Medical, Inc. | 1.05 Million USD | -299.772% |
| Heart Tronics, Inc. | 54.99 Thousand USD | -7554.192% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | -4416.839% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 130.531% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 86.037% |
| VMS Rehab Systems, Inc. | 133.52 USD | -3152553.535% |
| Guided Therapeutics, Inc. | 1.46 Million USD | -186.941% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | -567.189% |
| Odyssey Group International, Inc. | 2.1 Million USD | -99.707% |
| United American Healthcare Corporation | -9.32 Million USD | 145.132% |
| ECGI Holdings, Inc. | 3.17 Million USD | -32.737% |
| Capital Group Holdings, Inc. | -3508.00 USD | 120094.954% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | -1502.869% |
| Urologix, Inc. | 4.61 Million USD | 8.788% |
| Nexeon MedSystems Inc. | 3.33 Million USD | -26.362% |
| SS Innovations International, Inc. | 1.18 Million USD | -255.122% |
| Qualis Innovations, Inc. | 6671.00 USD | -63000.33% |
| Smith & Nephew plc | 2.77 Billion USD | 99.848% |
| NIOX Group Plc | -23.93 Million USD | 117.589% |
| Fuse Medical, Inc. | 1.75 Million USD | -139.786% |
| Broncus Holding Corporation | -81.42 Million USD | 105.17% |
| Brain Scientific Inc. | 2.11 Million USD | -98.955% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 81.438% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | -10541.411% |